5AM Venture Management, LLC - Q3 2020 holdings

$380 Million is the total value of 5AM Venture Management, LLC's 9 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .

 Value Shares↓ Weighting
AKUS  Akouos Inc.$105,334,000
+1.6%
4,605,7840.0%27.70%
+22.0%
FIXX  Homology Medicines, Inc.$59,234,000
-29.6%
5,535,9190.0%15.58%
-15.4%
APRE  Aprea Therapeutics, Inc.$53,236,000
-38.0%
2,212,6540.0%14.00%
-25.5%
IDYA  IDEAYA Biosciences, Inc.$43,496,000
-11.6%
3,463,0660.0%11.44%
+6.1%
CABA  Cabaletta Bio, Inc.$39,775,000
-2.7%
3,669,2630.0%10.46%
+16.8%
SCPH  scPharmaceuticals Inc.$28,544,000
+1.2%
3,831,4740.0%7.51%
+21.5%
ARVN  Arvinas, Inc.$23,610,000
-29.6%
1,000,0000.0%6.21%
-15.5%
CRNX  Crinetics Pharmaceuticals, Inc.$21,347,000
-10.6%
1,362,2860.0%5.61%
+7.4%
CDTX  Cidara Therapeutics, Inc.$5,719,000
-22.8%
2,006,5110.0%1.50%
-7.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HOMOLOGY MEDICINES INC16Q3 202326.6%
ARVINAS INC16Q3 202314.3%
Crinetics Pharmaceuticals, Inc.16Q3 202312.8%
SCPHARMACEUTICALS INC16Q3 20237.5%
CIDARA THERAPEUTICS INC16Q3 20231.7%
IDEAYA BIOSCIENCES INC14Q1 202311.4%
VOR BIOPHARMA INC11Q3 202351.9%
CABALETTA BIO INC11Q2 202214.2%
AKOUOS INC10Q3 202227.7%
IMPEL PHARMACEUTICALS INC10Q3 20237.1%

View 5AM Venture Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-03
13F-HR2021-11-15

View 5AM Venture Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (380296000.0 != 380295000.0)

Export 5AM Venture Management, LLC's holdings